FIRST AMONG EQUALS: A COMPARATIVE STUDY OF THE EFFECT OF HYDROCHLOROTHIAZIDE AND CHLORTHALIDONE ON RECENTLY DIAGNOSED HYPERTENSIVES
Abstract
Objective: Thiazide diuretics have been the first choice to treat stable, uncomplicated, essential hypertension; hydrochlorothiazide (HCTZ) being
the most preferred. Another thiazide, chlorthalidone is available since long and is reported to be equally efficacious if not better in treating primary
hypertension.
Aim: To compare the efficacy and safety of HCTZ and chlorthalidone in the management of primary essential hypertension.
Methods: We compared these two drugs in a randomized, single-blinded, intention to treat study. Participants with essential hypertension received
either chlorthalidone 12.5 mg OD or HCTZ 25 mg OD for a period of 12-week. The results were compared on the basis of 12 hourly ambulatory
blood pressure (BP) monitoring; fortnightly record of serum potassium, and failure of treatment (i.e., the need of additional antihypertensive drug
or incrementation in the dose of thiazides).
Results: Out of 114,44 in chlorthalidone group and 39 in HCTZ group completed our study. There was a significant mean fall in BP by −11.89/−9.86
in the morning time and by −11.12/−7.56 in the evening time in group H receiving HCTZ 25 mg OD. In chlorthalidone group, this mean fall was by
−16.45/−12.38 in the morning time and by −15.73/−10.86 in the evening time. After 12 weeks, night time BP control was better in chlorthalidone
group (127.91±5.01) than HCTZ (132.67±5.19) (p=0.001). Both drugs decreased serum potassium levels, but this decrease was marginally more with
HCTZ (3.777±0.601 vs. 3.891±0.534), statistically non-significant when compared to each other (p>0.05).
Conclusion: Chlorthalidone is better than HCTZ in controlling BP throughout the day without causing any significant complication.
Keywords: Diuretics, Antihypertensive effect, Hydrochlorothiazide, Chlorthalidone, Hypokalemia.
Downloads
References
Gupta R, Guptha S. Strategies for initial management of hypertension.
Indian J Med Res 2010;132:531-42.
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C,
Handler J, et al 2014 evidence-based guideline for the management
of high blood pressure in adults: Report from the panel members
appointed to the Eighth Joint National Committee (JNC 8). JAMA
;311(5):507-20.
ALLHAT Officers and Coordinators for the ALLHAT Collaborative
Research Group. The Antihypertensive and Lipid-Lowering Treatment
to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive
patients randomized to angiotensin-converting enzyme inhibitor or
calcium channel blocker vs. diuretic: The Antihypertensive and LipidLowering
Treatment
to Prevent Heart Attack
Trial
(ALLHAT).
JAMA
;288(23):2981-97.
Ellison DH, Velázquez H, Wright FS. Thiazide-sensitive sodium chloride
cotransport in early distal tubule. Am J Physiol 1987;253:F546-54.
Asian J Pharm Clin Res, Vol 8, Issue 6, 2015, 195-198
Kumar et al.
Salvetti A, Ghiadoni L. Thiazide diuretics in the treatment of
hypertension: An update. J Am Soc Nephrol 2006;17 4 Suppl 2:S25-9.
Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus
chlorthalidone: Evidence supporting their interchangeability.
Hypertension 2004;43(1):4-9.
Sica DA. Chlorthalidone: Has it always been the best thiazide-type
diuretic? Hypertension 2006;47(3):321-2.
Woodman R, Brown C, Lockette W. Chlorthalidone decreases platelet
aggregation and vascular permeability and promotes angiogenesis.
Hypertension 2010;56(3):463-70.
Ernst ME, Lund BC. Renewed interest in chlorthalidone: Evidence
from the Veterans Health Administration. J Clin Hypertens (Greenwich)
;12(12):927-34.
Olde Engberink RH, Frenkel WJ, van den Bogaard B, Brewster LM,
Vogt L, van den Born BJ. Effects of thiazide-type and thiazide-like
diuretics on cardiovascular events and mortality: Systematic review
and meta-analysis. Hypertension 2015;65(5):1033-40.
Ernst ME, Carter BL, Goerdt CJ, Steffensmeier JJ, Phillips BB,
Zimmerman MB, et al. Comparative antihypertensive effects of
hydrochlorothiazide and chlorthalidone on ambulatory and office blood
pressure. Hypertension 2006;47(3):352-8.
Dorsch MP, Gillespie BW, Erickson SR, Bleske BE, Weder AB.
Chlorthalidone reduces cardiovascular events compared with
hydrochlorothiazide: A retrospective cohort analysis. Hypertension
;57(4):689-94.
Roush GC, Buddharaju V, Ernst ME. Is chlorthalidone better than
hydrochlorothiazide in reducing cardiovascular events in hypertensives?
Curr Opin Cardiol 2013;28(4):426-32.
Neff KM, Nawarskas JJ. Hydrochlorothiazide versus chlorthalidone in
the management of hypertension. Cardiol Rev 2010;18(1):51-6.
Dhalla IA, Gomes T, Yao Z, Nagge J, Persaud N, Hellings C, et al.
Chlorthalidone versus hydrochlorothiazide for the treatment of
hypertension in older adults: A population-based cohort study. Ann
Intern Med 2013;158(6):447-55.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.